Saiping Jiang

2.6k total citations · 1 hit paper
41 papers, 2.1k citations indexed

About

Saiping Jiang is a scholar working on Molecular Medicine, Epidemiology and Molecular Biology. According to data from OpenAlex, Saiping Jiang has authored 41 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Medicine, 9 papers in Epidemiology and 8 papers in Molecular Biology. Recurrent topics in Saiping Jiang's work include Antibiotic Resistance in Bacteria (10 papers), Antibiotic Use and Resistance (6 papers) and Pharmaceutical Practices and Patient Outcomes (5 papers). Saiping Jiang is often cited by papers focused on Antibiotic Resistance in Bacteria (10 papers), Antibiotic Use and Resistance (6 papers) and Pharmaceutical Practices and Patient Outcomes (5 papers). Saiping Jiang collaborates with scholars based in China, United States and Czechia. Saiping Jiang's co-authors include Yongzhong Du, Fuqiang Hu, Yi-Qing Ye, Su Zeng, Hong Yuan, Jing Qi, Ping Yang, Xiaoying Ying, Di Liu and Feiyang Jin and has published in prestigious journals such as Nature Communications, Biomaterials and Journal of Agricultural and Food Chemistry.

In The Last Decade

Saiping Jiang

37 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

ROS-responsive nano-drug delivery system combining mitochondria-targeting ceria nanoparticles with atorvastatin for acute kidney injury

2020 266 citations Hui Yu, Feiyang Jin et al. Theranostics profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Saiping Jiang China	20	662	580	281	263	245	41	2.1k
Mohamed A. Morsy Egypt	38	1.0k 1.5×	497 0.9×	140 0.5×	215 0.8×	287 1.2×	192	4.3k
Gang Cheng China	25	534 0.8×	723 1.2×	304 1.1×	319 1.2×	76 0.3×	90	2.4k
Maria Ángelés Solinís Spain	30	1.8k 2.7×	979 1.7×	247 0.9×	383 1.5×	186 0.8×	91	3.5k
Ali Alqahtani Saudi Arabia	28	906 1.4×	300 0.5×	141 0.5×	180 0.7×	208 0.8×	176	2.8k
Sadhna Sharma India	30	708 1.1×	747 1.3×	187 0.7×	465 1.8×	119 0.5×	88	2.6k
Mohammadreza Abbaspour Iran	26	331 0.5×	459 0.8×	203 0.7×	365 1.4×	214 0.9×	99	1.9k
Thomas A. Robertson Australia	22	396 0.6×	531 0.9×	234 0.8×	111 0.4×	143 0.6×	45	2.3k
Teruo Murakami Japan	30	817 1.2×	508 0.9×	260 0.9×	269 1.0×	67 0.3×	135	3.2k
Nobuhito Shibata Japan	27	411 0.6×	757 1.3×	172 0.6×	218 0.8×	95 0.4×	96	2.2k

Countries citing papers authored by Saiping Jiang

Since Specialization

Citations

This map shows the geographic impact of Saiping Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Saiping Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Saiping Jiang more than expected).

Fields of papers citing papers by Saiping Jiang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Saiping Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Saiping Jiang. The network helps show where Saiping Jiang may publish in the future.

Co-authorship network of co-authors of Saiping Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Saiping Jiang. A scholar is included among the top collaborators of Saiping Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Saiping Jiang. Saiping Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yang, Ju, Lixing Weng, Xiaohui Yang, et al.. (2025). Advances of Antimicrobial Peptides in the Treatment of Multidrug-Resistant Bacteria. BioDrugs. 39(6). 899–922.

Bai, Yanan, et al.. (2025). Multi-omics reveals the synergistic mechanism of polymyxin B and diethyldithiocarbamate against Pseudomonas aeruginosa. International Journal of Antimicrobial Agents. 66(5). 107569–107569.

Kong, Limin, Fan Li, Yujun Zhou, et al.. (2025). Identification of CD38 ^high Monocyte as a Candidate Diagnostic Biomarker and Therapeutic Target for Sepsis. Advanced Science. 12(23). e2500457–e2500457. 5 indexed citations

Yang, Ping, Qingyu Li, Xumei Li, et al.. (2024). A multicenter clinical study on the incidence and influencing factors of cephalosporin-induced anaphylaxis. Journal of Zhejiang University (Medical Sciences). 53(5). 615–622. 1 indexed citations

Liu, Di, Yanling Song, Hui Chen, et al.. (2023). Anti-VEGFR2 F(ab′)2 drug conjugate promotes renal accumulation and glomerular repair in diabetic nephropathy. Nature Communications. 14(1). 8268–8268. 7 indexed citations

Zhang, Yanfang, et al.. (2023). Acute kidney injury associated with colistin sulfate vs. polymyxin B sulfate therapy: A real-world, retrospective cohort study. International Journal of Antimicrobial Agents. 63(1). 107031–107031. 12 indexed citations

Liu, Di, Gaofeng Shu, Feiyang Jin, et al.. (2020). ROS-responsive chitosan-SS31 prodrug for AKI therapy via rapid distribution in the kidney and long-term retention in the renal tubule. Science Advances. 6(41). 161 indexed citations

Yu, Hui, Feiyang Jin, Di Liu, et al.. (2020). ROS-responsive nano-drug delivery system combining mitochondria-targeting ceria nanoparticles with atorvastatin for acute kidney injury. Theranostics. 10(5). 2342–2357. 266 indexed citations breakdown →

Liu, Xuejiao, et al.. (2020). Comamonas kerstersii bacteremia. Médecine et Maladies Infectieuses. 50(3). 288–290. 7 indexed citations

10.

Jiang, Saiping, Rongrong Wang, Lu Li, et al.. (2020). Liver Injury in Critically Ill and Non-critically Ill COVID-19 Patients: A Multicenter, Retrospective, Observational Study. Frontiers in Medicine. 7. 347–347. 26 indexed citations

11.

Wang, Rongrong, Limin Kong, Qiang Xu, et al.. (2020). On-ward participation of clinical pharmacists in a Chinese intensive care unit for patients with COVID-19: A retrospective, observational study. Research in Social and Administrative Pharmacy. 17(1). 1853–1858. 15 indexed citations

12.

Wang, Rongrong, et al.. (2019). <p>Trends and correlation of antibiotic susceptibility and antibiotic consumption at a large teaching hospital in China (2007–2016): a surveillance study</p>. Therapeutics and Clinical Risk Management. Volume 15. 1019–1027. 11 indexed citations

13.

Yang, Ping, Yunbo Chen, Saiping Jiang, et al.. (2018). Association between antibiotic consumption and the rate of carbapenem-resistant Gram-negative bacteria from China based on 153 tertiary hospitals data in 2014. Antimicrobial Resistance and Infection Control. 7(1). 137–137. 88 indexed citations

14.

Hu, Jingbo, Shujuan Li, Xu-Qi Kang, et al.. (2018). CD44-targeted hyaluronic acid-curcumin prodrug protects renal tubular epithelial cell survival from oxidative stress damage. Carbohydrate Polymers. 193. 268–280. 77 indexed citations

15.

Liu, Lin, Hongyu Yang, Jing Miao, et al.. (2018). Off-label prescriptions in intensive care unit: the Chinese experience. Therapeutics and Clinical Risk Management. Volume 14. 195–202. 4 indexed citations

16.

Yang, Ping, Na Chen, Rongrong Wang, Lu Li, & Saiping Jiang. (2016). Inappropriateness of medication prescriptions about chronic kidney disease patients without dialysis therapy in a Chinese tertiary teaching hospital. Therapeutics and Clinical Risk Management. Volume 12. 1517–1524. 19 indexed citations

17.

Zhao, Qingwei, et al.. (2014). Implementation of pharmacists’ interventions and assessment of medication errors in an intensive care unit of a Chinese tertiary hospital. Therapeutics and Clinical Risk Management. 10. 861–861. 18 indexed citations

18.

Zheng, Beiwen, Saiping Jiang, Zemin Xu, Yonghong Xiao, & Lanjuan Li. (2014). Severe infective endocarditis with systemic embolism due to community associated methicillin-resistant Staphylococcus aureus ST630. The Brazilian Journal of Infectious Diseases. 19(1). 85–89. 10 indexed citations

19.

Jiang, Saiping, Yanyan Xu, Xingguo Zhang, et al.. (2014). Improving antimicrobial dosing in critically ill patients receiving continuous venovenous hemofiltration and the effect of pharmacist dosing adjustment. European Journal of Internal Medicine. 25(10). 930–935. 15 indexed citations

20.

Yuan, Hong, Saiping Jiang, Yongzhong Du, et al.. (2009). Strategic approaches for improving entrapment of hydrophilic peptide drugs by lipid nanoparticles. Colloids and Surfaces B Biointerfaces. 70(2). 248–253. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact